Table 4.
Bowel movement (BM) frequency and Bristol Stool Scale results for participants consuming Zespri® SunGold kiwifruit (Actinidia chinensis var. chinensis ‘Zesy002’) with and without skin 1.
Participant Group | Trial Phase | No. of CSBMs Per Week | No. of BMs Per Week | No. of CBMs Per Week | No. of SBMs Per Week | No. of Strained BMs Per Week | Bristol Stool Scale |
---|---|---|---|---|---|---|---|
Healthy | Baseline | 7.6 (5.4) | 10.5 (5.2) | 9.7 (5.6) | 8.3 (5.2) | 1.1 (1.5) | 3.3 (0.7) |
Kiwifruit flesh | 7.8 (5.1) | 10.1 (5.3) | 9.7 (5.6) | 8.1 (5.0) | 0.6 (1.0) | 4.0 * (1.0) | |
Kiwifruit flesh and skin | 9.8 (5.7) | 11.4 (5.7) | 11.1 (6.0) | 10.1 (5.4) | 0.1 (0.3) | 3.9 * (0.7) | |
IBS-C | Baseline | 6.7 (4.8) | 9.5 (5.6) | 6.7 (4.8) | 9.4 (5.6) | 2.8 (2.9) | 3.5 (1.0) |
Kiwifruit flesh | 8.4 (7.0) | 11.0 (7.5) | 8.7 (6.9) | 10.7 (7.7) | 2.3 (2.7) | 3.9 (1.0) | |
Kiwifruit flesh and skin | 9.2 * (5.8) | 11.4 (6.2) | 8.7 (6.9) | 11.3 (6.1) | 1.9 (2.5) | 3.8 (1.1) | |
p Values | |||||||
Treatment | <0.001 | 0.020 | <0.001 | 0.009 | 0.007 | <0.001 | |
Group | 0.871 | 0.995 | 0.303 | 0.377 | 0.004 | 0.953 | |
Treatment × Group | 0.405 | 0.174 | 0.151 | 0.422 | 0.972 | 0.390 |
1 Data presented as the mean (standard deviation); complete spontaneous bowel movement (CSBM); complete bowel movement (CBM); spontaneous bowel movement (SBM); * mean significantly different from baseline based on least significant difference (p = 0.0055).